The India Advanced Wound Care Management Market, estimated at USD 290.5 Mn in 2025, is expected to exhibit a CAGR of 5.1% and reach USD 411.5 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
To bring patient-centered, high-quality care to more communities, the various market players are engaged in the adoption of growth strategies, which is expected to offer significant growth opportunities for players in India advanced wound care management market. For instance, on June 13, 2025, Ministry of science and technology, India published an article that states that the research Alicorn CholeDerm wound dressing, technology was transferred to Alicorn Medical, a start-up biopharmaceutical company in the technology incubation facility of the institute namely TIMed. The recent growth of technology is scaffold has the ability to mitigate fibrotic scarring in rats suffering an experimental myocardial infarction.
India Advanced Wound Care Management Market – Impact of Coronavirus (COVID-19) Pandemic
Since the outbreak of the COVID-19 epidemic in December 2025, the disease has spread to more than 100 countries worldwide and has been declared a public health emergency by the World Health Organization. The emergence of the coronavirus (COVID-19) had claimed more than 27 million lives worldwide, according to a report by the World Health Organization. The COVID pandemic has changed the homeostasis of the medical world and is affecting millions of people worldwide. The global crisis has consequences for the world economy in addition to health.
Hospitals and acute care facilities are currently experiencing patient scarcity due to the COVID-19 epidemic. Any procedure or service that is determined to be "non-essential" is consequently stopped. Wound care has already been designated as 'non-essential' in many hospitals.
A COVID-19 infection puts patients with diabetes, hypertension, venous insufficiency, and peripheral artery disease at significant risk of developing additional infections, sepsis, amputations, and possibly death. Additionally, non-healing wounds that go untreated and unmanaged because wound care solutions are not readily available can result in health problems like infection, sepsis, the need for limb amputation, and even death.